# A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery

> **NCT00519961** · NA · UNKNOWN · sponsor: **Hoffmann-La Roche** · enrollment: 1800 (estimated)

## Conditions studied

- Peripheral Vascular Disease

## Interventions

- **DEVICE:** Elecsys®proBNP

## Key facts

- **NCT ID:** NCT00519961
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-02
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 1800 (ESTIMATED)
- **Last updated:** 2011-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00519961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00519961, "A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00519961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*